Abstract 2454: Imaging pancreatic ductal adenocarcinoma using a zinc-sensitive MRI contrast agent: A novel method to detect early-stage PDAC lesions
Authors: Mozhdeh Sojoodi, Ian Ramsay, Eric Gale, Stephen C. Barrett, Motaz Qadan, Peter Caravan, Kenneth K. Tanabe, Veronica Clavijo Jordan
Journal: Cancer Research (2022)

Abstract Background: Zinc content and its flux from the exocrine pancreas are both novel candidates for molecular imaging of pancreatic ductal adenocarcinoma (PDAC) due to the markedly dysregulated homeostasis in PDAC lesions. Here, we introduce the use of a Gd-based zinc probe (GdL) to monitor stimulated exocrine function in the healthy and PDAC bearing mouse pancreas by MRI. Methods: Male adult mice were implanted with syngeneic PDAC cells into the pancreas and allowed to form PDAC for 1 and 2 weeks. Healthy mice were used as controls. Mice were fasted overnight and imaged in a 4.7 T scanner. Two 2D T1-weighted gradient echo scans were obtained as baseline (TE/TR = 2.9/125 ms, Avg = 4). Mice then received either 1) 0.07mmol/kg GdL (i.v.) plus 10 ug/kg caerulein (i.p.), 2) 0.07mmol/kg GdL (i.v.) plus Saline (i.p.), or 3) 0.01 mmol/kg Gd-DOTA (i.v.). Immediately following injections, serial 2D T1-weighted gradient echo scans were obtained for 25 minutes. PDAC mice receiving saline were considered as negative controls. Change in contrast to-noise ratio (CNR) of tumor and pancreas was quantified and reported as a function of time. Tumor and pancreas tissue were then fixed, and histological analysis was done to characterize the expression of zinc transporters in healthy pancreas and PDAC tissues. Results: Secretagogue-stimulated zinc secretion (SSZS) MRI of the exocrine pancreas relies on evoking zinc release from intracellular stores from acinar and ductal cells. After i.p. injection of the secretagogue caerulein in fasted healthy animals, we observed only a small enhancement in the pancreas. However, both groups of animals carrying orthotopically implanted PDAC cells (1-wk and 2-wks) responded in hyper-secretory fashion. Negative controls (saline group) did not show significant pancreatic or tumor enhancement. Importantly, the effect of caerulein in PDAC animals and the increase in overall pancreatic enhancement were only found in PDAC tumor bearing animals. Dysregulation of zinc trafficking was confirmed by immunohistochemistry staining for the zinc import transporters ZIP3 and ZIP4. These transporters were upregulated only in PDAC-bearing pancreas and the positive staining was concentrated mostly in the tumor parenchyma and gradually dissipated in the surrounding pancreatic tissue. Conclusions: Zinc flux is markedly upregulated in PDAC. By stimulating the natural zinc secretion from exocrine pancreatic cells using an exogenous secretagogue, caerulein, we can non-invasively monitor early malignant transformations in pancreatic parenchyma and tumor cells by MRI with a Gd-based zinc sensitive probe. Citation Format: Mozhdeh Sojoodi, Ian Ramsay, Eric Gale, Stephen C. Barrett, Motaz Qadan, Peter Caravan, Kenneth K. Tanabe, Veronica Clavijo Jordan. Imaging pancreatic ductal adenocarcinoma using a zinc-sensitive MRI contrast agent: A novel method to detect early-stage PDAC lesions [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 2454.